Apremilast for treatment of recalcitrant aphthous stomatitis
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference7 articles.
1. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis;Schafer;Br J Pharmacol,2010
2. A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults;Samrao;Arch Dermatol,2012
3. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis;Baughman;Arch Dermatol,2012
4. An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case series;Paul;J Am Acad Dermatol,2013
5. Apremilast for Behçet's syndrome–a phase 2, placebo-controlled study;Hatemi;N Engl J Med,2015
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Apremilast for severe recurrent aphthous stomatitis: A prospective pilot study;Journal of the American Academy of Dermatology;2023-02
2. Evolving utility of apremilast in dermatological disorders for off-label indications;Clinical and Experimental Dermatology;2022-12-01
3. Intérêt de l’Aprémilast dans les stomatites aphteuses récurrentes idiopathiques : étude de deux cas cliniques;La Revue de Médecine Interne;2022-05
4. Recurrent aphthous stomatitis: A comprehensive review and recommendations on therapeutic options;Dermatologic Therapy;2022-04-18
5. Development of an amorphous based sustained release system for apremilast a selective phosphodiesterase 4 (PDE4) inhibitor;International Journal of Pharmaceutics;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3